Get the Stockscreener App
64.73
0.23%
-0.15
After Hours:
64.73
Henry Schein Inc stock is traded at $64.73, with a volume of 1.70M.
It is down -0.23% in the last 24 hours and down -4.44% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$64.88
Open:
$64.68
24h Volume:
1.70M
Relative Volume:
1.00
Market Cap:
$7.85B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
26.53
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
-1.33%
1M Performance:
-4.44%
6M Performance:
+3.24%
1Y Performance:
-7.52%
1-Day Range:
$63.63
$65.15
1-Week Range:
$63.63
$67.35
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
64.73 | 7.87B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
755.75 | 93.30B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
310.61 | 59.85B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
CAH
Cardinal Health Inc
|
157.77 | 37.22B | 222.58B | 1.57B | 1.85B | 6.4395 |
|
AHG
Akso Health Group Adr
|
1.56 | 895.20M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Peering Into Henry Schein Inc's Recent Short Interest - Sahm
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein subsidiary allegedly compromised by Lynx ransomware - SC Media
July 2026 Options Now Available For Henry Schein (HSIC) - Nasdaq
Understanding Henry Schein Inc.’s price movement2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com
Tick level data insight on Henry Schein Inc. volatilityWeekly Profit Recap & Real-Time Stock Price Movement Reports - newser.com
Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET - ADVFN
How to forecast Henry Schein Inc. trends using time seriesMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Real time breakdown of Henry Schein Inc. stock performanceJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
What Fibonacci levels say about Henry Schein Inc. rebound2025 Price Action Summary & Reliable Price Breakout Alerts - newser.com
Henry Schein Reports Record Second-Quarter 2021 Financial Results From Continuing Operations - ADVFN
Henry Schein (NASDAQ:HSIC) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Attackers claim an attack on Henry Schein’s TriMed - Cybernews
Is Henry Schein Inc. stock bottoming outTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Using Ichimoku Cloud for Henry Schein Inc. technicalsMarket Risk Analysis & Consistent Profit Trading Strategies - newser.com
How to manage a losing position in Henry Schein Inc.Quarterly Trade Report & High Win Rate Trade Tips - newser.com
Is now a turning point for Henry Schein Inc.July 2025 Trends & Precise Swing Trade Entry Alerts - newser.com
Applications Open for 2025 Henry Schein Student Outreach Grants - Orthodontic Products
Barrington Research Maintains Price Target on Henry Schein at $78, Rating is Outperform - MarketScreener
Barrington Research Adjusts PT on Henry Schein to $56 From $78, Maintains Outperform Rating - MarketScreener
Henry Schein Cares Opens Applications for its Global Student Outreach Program - Dentistry Today
Subscribili Joins Henry Schein One API Exchange as an Authorized Integration Vendor - PRWeb
What Does Henry Schein, Inc.'s (NASDAQ:HSIC) Share Price Indicate? - 富途牛牛
Root Canal Files Market to Witness Significant Growth and Gain - openPR.com
Henry Schein (HSIC) Valuation: Taking Stock After Q2 Earnings Miss and Weaker U.S. Dental Demand - Yahoo Finance
What analysts say about Henry Schein Inc stockShort-Term Trading Alerts & Minimal Capital Growth Plans - earlytimes.in
What drives Henry Schein Inc stock priceTechnical Analysis Insights & Crush the Market with Breakout Winners - earlytimes.in
Henry Schein credit supervisor pleads guilty to embezzling $1.6M from the Melville-based company - Newsday
Henry Schein Announces $750 Million Share Repurchase Plan - ADVFN
Why Henry Schein (HSIC) Shares Are Trading Lower Today - Yahoo Finance
Henry Schein Stock: Is HSIC Underperforming the Health Care Sector? - MSN
Henry Schein Stock: Is HSIC Underperforming The Health Care Sector? - Barchart.com
Assenagon Asset Management S.A. Buys 28,089 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Sees Steady Smile As Dental Market Growth Holds: Analyst - Sahm
Henry Schein at Bank of America Conference: Strategic Moves and Market Insights - Investing.com Australia
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Henry Schein Inc Stock (HSIC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LASKAWY PHILIP A | Director |
Mar 19 '25 |
Sale |
71.04 |
2,604 |
184,999 |
24,805 |
| Connett Bradford C | CEO, NA Distribution Group |
Mar 19 '25 |
Sale |
71.15 |
4,036 |
287,161 |
62,688 |
4.29%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):